Cargando…
Exhaled nitric oxide is not a biomarker for idiopathic pulmonary arterial hypertension or for treatment efficacy
BACKGROUND: Idiopathic pulmonary arterial hypertension (IPAH) is a fatal illness. Despite many improvements in the treatment of these patients, there is no unique prognostic variable available to track these patients. The aim of this study was to evaluate the association between fractional exhaled n...
Autores principales: | Malekmohammad, Majid, Folkerts, Gert, Kashani, Babak Sharif, Naghan, Parisa Adimi, Dastenae, Zahra Habibi, Khoundabi, Batoutl, Garssen, Johan, Mortaz, Esmaeil, Adcock, Ian M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819396/ https://www.ncbi.nlm.nih.gov/pubmed/31664957 http://dx.doi.org/10.1186/s12890-019-0954-z |
Ejemplares similares
-
Correction to: Exhaled nitric oxide is not a biomarker for idiopathic pulmonary arterial hypertension or for treatment efficacy
por: Malekmohammad, Majid, et al.
Publicado: (2019) -
Possibility of Applying Heart Rate Variability as a Screening Method to High-Risk Obstructive Sleep Apnea Patients
por: Malekmohammad, Majid, et al.
Publicado: (2022) -
Nitric Oxide in the Pathogenesis and Treatment of Tuberculosis
por: Jamaati, Hamidreza, et al.
Publicado: (2017) -
Sleep Disorders and Mental Health in Menopausal Women in Tehran
por: Adimi Naghan, Parisa, et al.
Publicado: (2020) -
Silent hypoxia: higher NO in red blood cells of COVID-19 patients
por: Mortaz, Esmaeil, et al.
Publicado: (2020)